Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

UK study checks Real-World use of clotting drug for bleeding disorder

NCT ID NCT06433778

First seen Mar 23, 2026 · Last updated May 19, 2026 · Updated 10 times

Summary

This study looked back at medical records of 34 adults in the UK with von Willebrand disease (a common inherited bleeding disorder) who received a medicine called vonicog alfa (rVWF). The goal was to see how well it controlled bleeding episodes and helped during surgeries in real-world settings. Researchers also tracked hospital visits and costs. No new treatments were given—only existing data were reviewed.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VON WILLEBRAND DISEASE (VWD) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Imperial College Healthcare

    London, W2 1NY, United Kingdom

  • Leeds Teaching Hospital

    Leeds, LS9 7TF, United Kingdom

  • Liverpool University Hospital

    Liverpool, L7 8XP, United Kingdom

  • Manchester University

    Manchester, M13 9WL, United Kingdom

  • Oxford University Hospital

    Oxford, OX3 9DU, United Kingdom

  • Royal Free London

    London, NW3 2QG, United Kingdom

  • University Hospitals Birmingham

    Birmingham, B15 2GW, United Kingdom

Conditions

Explore the condition pages connected to this study.